Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

INTC vs PFE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PFE Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–4 Matrix Metrics)

PFE Overall Winner 6-Pillar Tally: INTC 2 – 4 PFE Matrix Metrics: INTC 4 – 6 PFE

As of Nov 20, 2026, Pfizer Inc. (PFE) is the stronger overall head-to-head candidate over Intel Corp (INTC) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). INTC carries a Unified Composite Score of 56.3/100 (HOLD) at $51.28 (28.6x Forward P/E, 10.3% operating margin), whereas PFE carries 49.4/100 (HOLD) at $27.40 (9.3x Forward P/E, 29.1% operating margin).

  • Composite vs. Pillar Nuance: While INTC currently prints a higher short-term Unified Composite Score (56.3/100 HOLD vs. PFE 49.4/100 HOLD), PFE captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (29.1% vs. 10.3% operating margin) and revenue trajectory (-0.4% vs. +20.9% YoY).
  • Technical & Structure Timing Caution: INTC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 27.8); meanwhile PFE trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 32.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About INTC vs PFE
INTC NASDAQ
Intel Corp
Semiconductors & Related Devices
$51.28
-7.97% 1D
Market Cap $296.2B
TTM Revenue $59.9B
Forward P/E 28.6x
Beta / 30D Vol 3.28β · 122% Vol
Unified Composite Score
56.3 / 100 HOLD
Tech 55.0 Fund 59.0 Flow 67.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -11.6%), weak momentum, RSI 28
RSI-14: 27.8 · SMA20: $64.90 · SMA50: $90.22
PFE NYSE Head-to-Head Winner
Pfizer Inc.
Pharmaceutical Preparations
$27.40
-0.51% 1D
Market Cap $157.0B
TTM Revenue $63.6B
Forward P/E 9.3x
Beta / 30D Vol 0.18β · 22% Vol
Unified Composite Score
49.4 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 68.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 32
RSI-14: 32.5 · SMA20: $29.32 · SMA50: $28.82

6-Pillar Scorecard Institutional Category Breakdown (INTC 2 – 4 PFE)

Columns: Metric · INTC · PFE
1. Valuation Multiples PFE
Forward P/E 28.6x 9.3x
Trailing P/E 32.4x 39.3x
PEG Ratio 0.50x 8.56x
EV / Revenue 5.4x 3.4x
2. Growth & Scale INTC
Revenue Growth (YoY) +20.9% -0.4%
Earnings Growth (YoY) -32.7% -9.7%
TTM Revenue (USD) $59.9B $63.6B
Market Cap $296.2B $157.0B
3. Profitability & Quality PFE
Gross Margin 40.2% 74.9%
Operating Margin 10.3% 29.1%
Net Profit Margin -20.1% 6.3%
Return on Equity (ROE) -9.6% 4.5%
4. Balance Sheet & Cash Flow PFE
Cash Generation (TTM) $3.77B $11.8B
Cash Flow Margin 6.3% 18.5%
Net Cash / Leverage $28.3B Net Debt (0.44x D/E) $60.8B Net Debt (0.70x D/E)
Dividend Yield None (0.00%) 7.66%
5. Options & Positioning PFE
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile 133.5% (64th %ile) 48.1% (58th %ile)
Put/Call OI Skew 1.23x (Put-Skewed) 0.62x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Markdown DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat INTC
OpEx & R&D Intensity 29.9% of Rev ($17.9B) 45.8% of Rev ($29.1B)
90D R&D Disclosures 5 papers 0 papers
Competitive Moat High Switching-Cost Moat Scale & Operating Efficiency Moat
Supply-Chain Role Integrated x86 CPU Designer & Domestic Foundry Operator Drug Manufacturers - General Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: INTC (4) vs PFE (6)
Institutional Metric INTC PFE Criterion Row Edge
Market Capitalization
Scale
$296.2B $157.0B Larger Scale INTC
Trailing P/E Ratio
Valuation
32.4x 39.3x Lower Multiple INTC
Forward P/E Ratio
Valuation
28.6x 9.3x Lower Multiple PFE
Revenue Growth (YoY)
Growth
+20.9% -0.4% Higher Growth INTC
Operating Margin (TTM)
Profitability
10.3% 29.1% Higher Margin PFE
Net Profit Margin
Profitability
-20.1% 6.3% Higher Margin PFE
Return on Equity (ROE)
Capital Efficiency
-9.6% 4.5% Higher ROE PFE
52-Week Range Position
Momentum
17% ($33–$142) 48% ($24–$31) Stronger Trend PFE
Beta / 30D Volatility
Risk Regime
3.28β · 122% Vol 0.18β · 22% Vol Lower Realized Risk PFE
Unified Institutional Score
Composite Signal
56.3 / 100 (HOLD) 49.4 / 100 (HOLD) Higher Composite INTC
Trailing 12M Revenue (USD)
Operating Scale
$59.9B $63.6B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
40.2% 74.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.50x PEG · 5.4x EV/Rev 8.56x PEG · 3.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$3.77B ($28.3B Net Debt (0.44x D/E)) $11.8B ($60.8B Net Debt (0.70x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PFE +30.09 pp
INTC: -40.02% · PFE: -9.93%
3M Horizon PFE +39.19 pp
INTC: -41.23% · PFE: -2.04%
6M Horizon PFE +63.0 pp
INTC: -57.21% · PFE: +5.79%
1Y Horizon INTC +35.93 pp
INTC: +46.06% · PFE: +10.13%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period INTC Revenue PFE Revenue INTC Op. Margin PFE Op. Margin Margin Leader
FY2018 $70.8B $40.8B 32.9% 27.3% INTC
FY2019 $72.0B $40.9B 30.6% 39.2% PFE
FY2020 $77.9B $41.6B 30.4% 22.0% INTC
FY2021 $79.0B $73.6B 24.6% 29.8% PFE
FY2022 $63.0B $91.8B 3.7% 34.2% PFE
FY2023 $54.2B $50.9B 0.2% 4.2% PFE
FY2024 $53.1B $63.6B -22.0% 12.6% PFE
FY2025 $52.9B $62.6B -4.2% 12.4% PFE

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
INTC BREAKDOWN
107d in phase · OBV DISTRIBUTION
Current IV 133.5%
IV Percentile 64th %ile
Put/Call OI Skew 1.23x (Put-Skewed)
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact INTC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PFE CONSOLIDATION
56d in phase · OBV DISTRIBUTION
Current IV 48.1%
IV Percentile 58th %ile
Put/Call OI Skew 0.62x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact PFE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $55.47 · IV 60.5%

INTC vs. PFE: Simulated 5-Day Option Payoffs & Capital Efficiency

Compare 100 shares of INTC ($5,547) vs. PFE ($2,886) against risk-defined 5-day vertical and put-wall option structures.

INTC Spot $55.47 · IV 60.5%
INTC Options Simulator →
5-DAY BULLISH SWING Liq A

Dec 18 $55 / $65 Bull Call Spread

Buy 1x $55C · Sell 1x $65C · 31d

Net Entry $348 Debit
T+5d @ +5% Move +$82 (+23%)
Max Risk / Buffer $348 Capped
5d Edge & Liquidity 0.8x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $47 / $45 Bull Put Spread

Sell 2x $47P · Buy 2x $45P · 31d

Net Entry $80 Credit
Max Credit / Yield +$80 (+25.0% RoM)
Max Risk / Buffer -16.0% Cushion ($320 Mgn)
5d Edge & Liquidity 80% PoP · Liq A
Simulate 5-Day Payoff →
PFE Spot $28.86 · IV 25.6%
PFE Options Simulator →
5-DAY BULLISH SWING Liq A

Dec 18 $29 / $30 Bull Call Spread

Buy 2x $29C · Sell 2x $30C · 31d

Net Entry $84 Debit
T+5d @ +5% Move +$52 (+62%)
Max Risk / Buffer $84 Capped
5d Edge & Liquidity 0.9x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Jan 15 '27 $27 / $25 Bull Put Spread

Sell 2x $27P · Buy 2x $25P · 59d

Net Entry $58 Credit
Max Credit / Yield +$58 (+17.0% RoM)
Max Risk / Buffer -7.4% Cushion ($342 Mgn)
5d Edge & Liquidity 77% PoP · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
INTC Moat Profile High Switching-Cost Moat
Integrated x86 CPU Designer & Domestic Foundry Operator
Operates dual client/server x86 processor franchises alongside domestic leading-edge wafer fabrication and advanced packaging investments.
OpEx & R&D Reinvestment 29.9% of Rev ($17.9B)
90D Engineering Disclosures 5 Published · Neuromorphic Computing
Mapped Supply-Chain Ecosystem (18 partners):
ASML Holding Taiwan Semiconductor Manufacturing Company Applied Materials Lam Research
Active 90D Technical Topics:
Edge AI / Inference Chips KV-Cache / Attention Memory Compression Low-Precision Inference (FP4/FP8) World Models / Embodied AI
PFE Moat Profile Scale & Operating Efficiency Moat
Drug Manufacturers - General Operator
Competes within the Drug Manufacturers - General value chain with $157.0B market capitalization and 29.1% operating margin.
OpEx & R&D Reinvestment 45.8% of Rev ($29.1B)
90D Engineering Disclosures 0 Published

Investor FAQ INTC vs PFE Key Questions & Quantitative Answers

As of Nov 20, 2026, Pfizer Inc. (PFE) is the stronger overall head-to-head candidate over Intel Corp (INTC) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). INTC carries a Unified Composite Score of 56.3/100 (HOLD) at $51.28 (28.6x Forward P/E, 10.3% operating margin), whereas PFE carries 49.4/100 (HOLD) at $27.40 (9.3x Forward P/E, 29.1% operating margin). Composite vs. Pillar Nuance: While INTC currently prints a higher short-term Unified Composite Score (56.3/100 HOLD vs. PFE 49.4/100 HOLD), PFE captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (29.1% vs. 10.3% operating margin) and revenue trajectory (-0.4% vs. +20.9% YoY). Technical & Structure Timing Caution: INTC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 27.8); meanwhile PFE trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 32.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

INTC leads the Growth & Scale pillar: INTC posts +20.9% YoY revenue growth and -32.7% YoY earnings growth on $59.9B TTM revenue (40.2% gross margin, 10.3% operating margin), compared with PFE at -0.4% YoY revenue growth and -9.7% YoY earnings growth on $63.6B TTM revenue (74.9% gross margin, 29.1% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), INTC cumulative revenue shifted -25.4% while PFE shifted +53.3%. In operating R&D and SG&A reinvestment, INTC deploys 29.9% of Rev ($17.9B) (5 90-day corporate R&D disclosures) versus 45.8% of Rev ($29.1B) (0 disclosures) for PFE.

PFE screens cheaper on headline valuation multiples. INTC trades at 28.6x Forward P/E, 32.4x Trailing P/E, 0.50x PEG, and 5.4x EV/Revenue (6.3% FCF margin), whereas PFE trades at 9.3x Forward P/E, 39.3x Trailing P/E, 8.56x PEG, and 3.4x EV/Revenue (18.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against INTC (-9.6% ROE) versus PFE (4.5% ROE) capital efficiency.

In options market volatility and institutional positioning, INTC carries 133.5% implied volatility (64th %ile, Elevated (60th–80th %ile)), a 1.23x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.28β · 122% Vol realized risk). By comparison, PFE carries 48.1% implied volatility (58th %ile, Balanced (25th–60th %ile)), a 0.62x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.18β · 22% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.